Doug Long of IQVIA Gives an Outlook on the Specialty Pharmacy Industry at Asembia

Payers and providers, often depicted as rivals, are on the same side when it comes to the 340B program that allows some hospitals to buy drugs at steep discounts, according to Milliman experts.

The actor expressed some regret as well as gratitude in talking about the death of his 33-year-old son from a rare form of sarcoma.

Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may loom large, though, as the administration and congressional Republicans look for ways to slash government spending as a way of offsetting major tax cuts.

The margins are small, and the services they provide must be “high touch.” 340B participation and cost-plus pricing are floated as tactics the pharmacies might use to improve their economics.

The splashy meeting with more than 7,000 people in attendance reflects the growth of the specialty pharmacy sector.